Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117971	Articles
99400	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 03/18/2025 at 13:35, 8 months 18 days ago

Jaguar Health Announces Reverse Stock Split

Reverse Stock Split Jaguar Health Nasdaq Compliance Institutional Investors Equiniti Trust
PRESS RELEASE

published on 03/18/2025 at 13:30, 8 months 18 days ago

Jaguar Health, Inc. Announces Reverse Stock Split
Jaguar Health, Inc. announces reverse stock split approval at Special Meeting of Stockholders to comply with Nasdaq's listing standards. Shares to trade on split-adjusted basis starting March 24, 2025

Shareholders Reverse Stock Split Nasdaq Listing Jaguar Health Stock Market
BRIEF

published on 03/13/2025 at 21:20, 8 months 23 days ago

Jaguar Health approuve les propositions et anticipe les développements clés en 2025

Crofelemer Jaguar Health Essais Cliniques Maladies Rares Approbation Réglementaire
BRIEF

published on 03/13/2025 at 21:20, 8 months 23 days ago

Jaguar Health Approves Proposals and Anticipates Key Developments in 2025

Crofelemer Clinical Trials Jaguar Health Regulatory Approval Rare Diseases
PRESS RELEASE

published on 03/13/2025 at 21:15, 8 months 23 days ago

Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders
Jaguar Health announces voting results of Special Meeting of Stockholders and expect first results in Q2 2025 for crofelemer trials in rare diseases. FDA meeting anticipated for Phase 3 OnTarget trial in breast cancer patients

Special Meeting Jaguar Health Rare Diseases Crofelemer Trials FDA Meeting
BRIEF

published on 02/27/2025 at 14:35, 9 months 6 days ago

Jaguar Health met en œuvre un plan de protection des droits des actionnaires dans le cadre d'une demande d'acquisition

Biotechnologie Santé Jaguar Réunion De La FDA Essais Sur Crofelemer Plan De Droits Des Actionnaires
BRIEF

published on 02/27/2025 at 14:35, 9 months 6 days ago

Jaguar Health Implements Stockholder Rights Plan Amid Acquisition Interest

Biotechnology Jaguar Health Crofelemer Trials FDA Meeting Stockholder Rights Plan
PRESS RELEASE

published on 02/27/2025 at 14:30, 9 months 6 days ago

Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value
Jaguar Health, Inc. announces results of crofelemer trials for rare diseases and adoption of Rights Plan to deter open-market accumulation. FDA meeting expected in Q2 2025 for breast cancer study results

Jaguar Health Crofelemer Trials FDA Meeting Rights Plan Breast Cancer Study
BRIEF

published on 02/19/2025 at 15:05, 9 months 14 days ago

Jaguar Health Advances Crofelemer Study in Europe

Crofelemer Clinical Trials Jaguar Health Orphan-Drug Designation Rare Diseases
BRIEF

published on 02/19/2025 at 15:05, 9 months 14 days ago

Jaguar Health fait progresser l'étude sur le Crofelemer en Europe

Crofelemer Essais Cliniques Désignation De Médicament Orphelin Maladies Rares Santé Jaguar

Accesswire

Published on 12/06/2025 at 02:00, 43 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 1 hour 28 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 2 hours 18 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 2 hours 43 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 3 hours 13 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 4 hours 28 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 4 hours 31 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 7 hours 45 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 8 hours 17 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 8 hours 28 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 3 hours 43 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 3 hours 43 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 3 hours 43 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 3 hours 43 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 9 hours 25 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE